COMMUNIQUÉS West-GlobeNewswire

Roche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

10/10/2024 - 07:00

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment [...]

Valneva Hosts Investor Day in New York City

10/10/2024 - 07:00

Live event and webcast TODAY at 10 AM ET Saint Herblain (France), October 10, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, is hosting an investor day today in New York City to [...]

Valneva organise une journée investisseurs aujourd’hui à New York

10/10/2024 - 07:00

Évènement en présentiel et retransmis en direct à 16h00 CET Saint Herblain (France), le 10 octobre 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, organise aujourd’hui une [...]

Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook

10/10/2024 - 07:00

Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 October 2024 – 7:00 AM CET Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms [...]

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

10/10/2024 - 07:00

Proof of concept clinical trial will evaluate leniolisib in PIDs with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes PIDs to include ALPS-FAS, CTLA4 haploinsufficiency, NFKB1 haploinsufficiency [...]

Manzil and Spectator Launch Strategic Partnership Advancing Tech-Enabled Home Care in Saudi Arabia, UAE, and Qatar

10/10/2024 - 07:00

ABU DHABI, United Arab Emirates and SITTARD, The Netherlands , Oct. 10, 2024 (GLOBE NEWSWIRE) -- Manzil Healthcare Services (“Manzil”), a leader in home health and disease management services in the Middle East, and [...]

Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D’Amelio Regarding Starboard Value

10/10/2024 - 03:19

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D’Amelio: We have decided not to be involved in the [...]

Lowell Farms Announces Management Services Agreements and Option to Purchase Two Southern California-Based Cannabis Retail Locations

09/10/2024 - 23:15

Strategic Agreements Unite Companies to Enhance Operational Synergies in the California Cannabis Market SALINAS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a [...]

Information on the total number of voting rights and shares

09/10/2024 - 22:35

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), October 9, 2024 , 10:35 pm CET / 4:35 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]

Informations sur le nombre total de droits de vote et d'actions

09/10/2024 - 22:35

INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 9 octobre 2024, 22:35h CET / 16:35h ET – Conformément à l'article 15 de la loi du 2 mai 2007 [...]

Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

09/10/2024 - 22:30

LOS ANGELES, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today that John S. Yu, M.D., Chief Executive Officer, will participate in a [...]

Publication relating to transparency notifications

09/10/2024 - 22:30

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 9, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the [...]

Publication relative à des notifications de transparence

09/10/2024 - 22:30

INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 9 octobre 2024 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à [...]

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

09/10/2024 - 22:15

RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2024 after [...]

ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

09/10/2024 - 22:15

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]

Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit

09/10/2024 - 22:15

WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick , President, CEO and Chairman of the [...]

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

09/10/2024 - 22:05

BEDFORD, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and [...]

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

09/10/2024 - 22:05

SEATTLE, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

09/10/2024 - 22:04

SAN JOSE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]